Table 3.
Patient | Pre* (ng/ml) | Post (ng/ml) | CSF (ng/ml) | CSF/Post (%) |
---|---|---|---|---|
15 | -- | 410,000 | 343 | 0.084 |
21 | 36,400 | 375,000 | 498 | 0.133 |
22 | 47,500 | 367,000 | 351 | 0.096 |
25 | < 500 | 334,000 | 276 | 0.083 |
26 | -- | 373,000 | 440 | 0.118 |
27 | 31,400 | 394,000 | < 250** | not calculated+ |
28 | -- | 649,000 | 272 | 0.042 |
30 | 36,900 | 349,000 | 1310 | 0.375 |
Levels detected in “Pre” serum samples likely from previous treatment with rituximab
Level was less than minimum detectable limit
Not calculated given that CSF level was less than detectable limit